Medbricks-Webcast

Medbricks-Webcast .

10/07/2025

Microbial science, from microbiomes to pathogens, reveals life at microscopic scales. Physics enables advanced imaging and quantum sensing, while AI/ML analyzes vast genomic data, predicting antibiotic resistance and microbial behavior, bridging biology with computational and physical innovations.
Stanley Maloy PhD, is a distinguished microbiologist and educator who has led San Diego State University’s Center for Microbial Sciences, served as Dean and Past President of the prestigious American Society for Microbiology. Dr Maloy advanced microbial genetics and infectious disease research, and championed science education and entrepreneurship.

10/03/2025

Storytelling through poetry heals the mind, weaving words into meaning and emotion. This timeless human trait nurtures empathy, reflection, and resilience, offering a gentle path to mental health improvement by connecting hearts, sharing struggles, and celebrating the strength within us all.
Renzo Del Castillo, healthcare executive and management consultant and turned poet, crafts verse exploring the immigrant experience, cultural transitions, and the complexities of adaptation. Through his collection “Still”, he illuminates empathy, human resilience, and the power of storytelling to connect hearts and minds.

10/01/2025

Healthcare operations are vital for implementing efficient systems, ensuring regulatory compliance, and delivering value-based care. By designing, scaling, and optimizing processes, they support patients navigating complex care needs, enabling better outcomes, seamless experiences, and sustainable healthcare delivery.
Jennifer Jaynes, MPH, is a visionary healthcare operations leader with 20+ years transforming complex systems. Results-driven and equity-focused, she has led nationwide telehealth launches, optimized behavioral health programs, and championed value-based care while mentoring the next generation of healthcare innovators.

09/30/2025

EGFR inhibitors (Epidermal Growth Factor Receptor) and other anticancer medicines block growth signals in cancer cells, slowing tumor progression, but also affect normal cells including those in the skin, causing significant rashes and patient discomfort. Developing drugs to reduce the skin-related toxicities are vital to maintain the intended dose of the anticancer therapy.
Sumant Ramachandra MD.PhD, a Harvard-trained physician-scientist and Wharton MBA, is a modern-day polymath. A pioneer in cancer biology, former leader at Pfizer, Merck and Baxter, he now leads Lutris Pharma’s mission to reduce cancer treatment-related side effects.

09/27/2025

The Stanford Innovation Summit last week was truly fascinating. We are at the heart of a healthcare revolution—listen to what industry leaders and futurists are saying about the future of medicine

Address

Atlanta, GA

Telephone

+14702225464

Website

Alerts

Be the first to know and let us send you an email when Medbricks-Webcast posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Medbricks-Webcast:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram